Original title: CDDO-EA Attenuates Acute Seizures and Suppresses Post-Status Epilepticus Epileptogenesis
Yara Sheeni, Prince Kumar Singh, Shweta Maurya, Sereen Sandouka +1 · October 2026
Epilepsy causes sudden electrical storms in the brain called seizures. Severe seizures often spark inflammation and cell damage, leading to lifelong epilepsy. Researchers tested a man-made molecule called CDDO-EA in two seizure models. It delayed and reduced immediate seizures while boosting protective enzymes that fight cell stress. In the long-term model, two weeks of treatment delayed future spontaneous seizures, lowered weekly attacks, and kept crucial brain cells alive.
A small electrical fire breaks out in the kitchen. Putting it out quickly prevents immediate destruction, but heat and smoke continue to weaken the surrounding walls, making future fires much more likely to start. In this paper, seizures are the initial fire, brain inflammation and oxidative stress are the lingering smoke damage, and the tested compound acts as both an extinguisher and a repair crew that keeps the walls from deteriorating.
Many seizure drugs only mask symptoms instead of stopping epilepsy from worsening over time. This work shows a molecule that not only dampens immediate seizures, but also protects brain cells and lowers the frequency of future attacks. For people at risk of developing chronic epilepsy after a severe brain injury, disease-modifying therapies like this could prevent long-term harm.
The abstract does not evaluate human patients, as all testing was conducted in experimental animal models. It also does not determine if brain protection persists long after treatment stops, nor does it identify the exact receptor-level target of the molecule.
Ask anything about this paper. Answers come from its abstract, and say so when the abstract doesn't cover your question.
CDDO-EA Attenuates Acute Seizures and Suppresses Post-Status Epilepticus Epileptogenesis — Yara Sheeni, Prince Kumar Singh, Shweta Maurya et al. — Antioxidants — doi:10.3390/antiox15101296
Abstract licence: CC BY
Explanation generated by Synthesis from the abstract — it is not the original paper.